Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when CATX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPerspective Therapeutics reports Q1 2026 financial results and business updates
Filed May 11, 2026 · Period ending May 11, 2026 · ~1 min read
Key Changes
-
high
Company disclosed financial results for the quarter ended March 31, 2026, along with recent business highlights. Specific figures and operational updates are contained in the attached press release.
Item 2.02 verify on EDGAR → -
low
Updated corporate presentation posted to company website, providing current investor materials and strategic overview.
Item 8.01 verify on EDGAR →
Summary
Perspective Therapeutics announced its first quarter 2026 financial results through a press release on May 11, 2026. The 8-K filing serves as the formal disclosure vehicle for these quarterly results, though the actual financial figures and business metrics are contained in the attached exhibits rather than the filing body itself. This is standard practice for earnings announcements.
For retail investors, the key takeaway is that Q1 results are now public and available for review. The company also refreshed its corporate presentation materials, which typically include updated pipeline information, clinical trial progress, and strategic priorities.
Investors should review the press release exhibit for specific revenue, cash position, and operational milestone details to assess the company's progress against expectations. Watch for any guidance updates or changes to clinical trial timelines that may affect the investment thesis.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 11, 2026, Perspective Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026 and providing recent business highlights.
The company disclosed its financial results for the first quarter ended March 31, 2026, along with recent business highlights. The actual financial figures and business updates are contained in the press release attached as Exhibit 99.1, which is not included in this 8-K body text.
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Also on May 11, 2026, the Company posted an updated corporate presentation on its website at www.perspectivetherapeutics.com. A copy of the presentation is filed as Exhibit 99.2 to this Form 8-K and is incorporated by reference into this Item 8.01.
The company updated its corporate presentation and made it available on its website. This is a routine disclosure of marketing materials with no specific business event or financial impact described in the 8-K body itself.
Event · Item 9.01 — Financial Statements and Exhibits
Perspective Therapeutics filed an 8-K attaching a press release and corporate presentation dated May 11, 2026.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
99.1
Press release issued by Perspective Therapeutics, Inc., dated May 11, 2026.
99.2
Corporate presentation.
The company filed an 8-K to attach two exhibits: a press release and a corporate presentation, both dated May 11, 2026. The 8-K body does not disclose the content of these documents, so the nature and materiality of any announcements cannot be determined from this filing alone.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify